Two doses of a simple tuberculosis vaccine after surgery support the immune system in fighting cancer cells and could significantly improve treatment outcomes for the most common form of bladder cancer, according to a pilot study involving 40 patients. Initial results of the RUTIVAC-1 study were presented at EAU25.
Autoren
- Birke Dikken
 
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
 
Related Topics
You May Also Like
- Patient-centered rounds in medicine
 
Aligning care with the patient
- HIV: antiretroviral therapy (ART)
 
Single-tablet regimens support adherence
- Rare pulmonary syndromes
 
Yellow nail and Swyer-James syndrome
- Vaccinations against viral respiratory infections
 
Influenza, Covid-19 and RSV – Update 2025
- GLP1-RA therapy
 
Improvement in either weight or HbA1c – but never both
- Suicide
 
Dealing with trauma after suicide loss: What do bereaved people experience as effective?
- COPD exacerbations
 
Fast therapy initiation is not much better than expected
- Lung cancer with EGFR mutation